XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Jan. 01, 2012
Jan. 02, 2011
Cash flows from operating activities:    
Net income (loss) $ 45,513 $ (29,061)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of properties 9,283 12,411
Amortization of intangibles 56,710 14,319
Stock-based compensation 4,450 5,643
Amortization of debt issuance costs 2,370 4,634
Amortization of debt discount 316 2,422
Deferred income taxes 41,219 38,347
Administrative related reorganization items   3,639
Cost of trading securities acquired for resale (348,491)  
Proceeds from trading security sold 415,916  
Interest credited/index credits to contractholder account balances 137,924  
Amortization of fixed maturity discounts and premiums 24,468  
Net recognized gains on investments and derivatives (133,907)  
Charges assessed to contractholders for mortality and administration (3,109)  
Deferred policy acquisition costs (39,780)  
Cash transferred to reinsurer (176,770)  
Non-cash restructuring and related charges 558  
Changes in operating assets and liabilities:    
Receivables (11,478) (7,844)
Inventories (41,624) 18,423
Prepaid expenses and other current assets 56,402 (1,013)
Accrued investment income 25,029  
Reinsurance recoverable (51,183)  
Accounts payable and accrued and other current liabilities (91,085) (125,045)
Future policy benefits (126)  
Liability for policy and contract claims 761  
Other operating 70,126 9,751
Net cash used in continuing operating activities (6,508) (53,374)
Net cash used in discontinued operating activities   (252)
Net cash used in operating activities (6,508) (53,626)
Cash flows from investing activities:    
Proceeds from investments sold, matured or repaid 1,739,746 33,954
Cost of investments acquired (654,479) (51,927)
Acquisitions, net of cash acquired (183,140) (10,278)
Capital expenditures (8,931) (8,152)
Other investing activities, net (100) (3)
Net cash provided by (used in) investing activities 893,096 (36,406)
Cash flows from financing activities:    
Proceeds from issuance of senior secured notes 217,000 345,055
Revolving credit facility activity 11,400 43,500
Proceeds from other debt financing 1,361 13,044
Repayments of debt (97,172) (70,224)
Debt issuance costs (4,020) (11,618)
Restricted cash placed in escrow   (360,133)
Treasury stock purchases of subsidiary (12,765) (3,241)
Contractholder account deposits 611,357  
Contractholder account withdrawals (540,825)  
Dividends paid on preferred stock (7,123)  
Other financing activities, net   874
Net cash provided by (used in) financing activities 179,213 (42,743)
Effect of exchange rate changes on cash and cash equivalents 1,627 (1,596)
Net increase (decrease) in cash and cash equivalents 1,067,428 (134,371)
Cash and cash equivalents at beginning of period 1,137,359 256,831
Cash and cash equivalents at end of period 2,204,787 122,460
Cash and cash equivalents - Consumer Products and Other 360,444 122,460
Cash and cash equivalents - Insurance 1,844,343 0
Total cash and cash equivalents at end of period $ 2,204,787 $ 122,460